Table 2. Baseline data of the included patients before start of the 1st treatment period.
| Parameter | oXiris mean ± SD |
ST mean ± SD |
P-value |
|---|---|---|---|
| Creatinine, mmol/l | 228 ± 49 | 316 ± 187 | 0.71 |
| Urea, mmol/l | 14.0 ± 3.1 | 20.8 ± 9.5 | 0.15 |
| Hemoglobin, g/l | 102 ± 7.1 | 97 ± 19.4 | 0.05 |
| Hematocrit | 0.3 ± 0.0 | 0.3 ± 0.1 | 0.03 |
| Base excess, mmol/l | -6.2 ± 4.0 | -5.3 ± 2.7 | 0.95 |
| Potassium, mmol/l | 3.9 ± 0.7 | 4.5 ± 1.0 | 0.16 |
| Lactate, mmol/l | 3.9 ± 2.6 | 2.2 ± 1.0 | 0.24 |
| Leukocyte count x106 | 23.4 ± 23.9 | 20.8 ± 12.1 | 0.96 |
| CRP, mg/l | 276 ± 63 | 269 ± 96 | 0.64 |
| Norepinephrine infusion, μ/kg/min | 0.48 ± 0.31 | 0.18 ± 0.12 | 0.02 |
| CRRT blood flow | 132 ± 69 | 121 ± 38 | 0.47 |
| CRRT effluent flow | 2634 ± 1185 | 2541 ± 1021 | 0.75 |
CRRT: continuous renal replacement therapy; CRP: C-reactive protein